STAFA, SWITZERLAND – Sonova Holding AG has announced upcoming appointments to its Management Board. Lilika Beck, currently Managing Director of Connect Hearing Canada in the Audiological Care business, will succeed Martin Grieder as Group Vice President (GVP) Consumer Hearing. Grieder tragically passed away in an accident in early April 2024.
Oliver Lux, presently Managing Director of Audiological Care Germany, has been appointed GVP Audiological Care, succeeding Christophe Fond. After successfully leading Sonova’s Audiological Care business for seven years, Fond will pursue an opportunity outside the hearing care industry.
Alistair Simpson will join the company as GVP Cochlear Implants, replacing Victoria Carr-Brendel, who has decided to retire from executive roles for personal reasons after heading Sonova’s Cochlear Implants business since 2019.
Arnd Kaldowski, CEO of Sonova, expressed gratitude for the dedication and significant contributions of Grieder, Fond, and Carr-Brendel over many years, noting their roles in driving the company’s success and advancing their respective businesses.
“During their tenure at Sonova, Martin, Christophe and Vicky have played important roles in driving Sonova’s overall success, significantly advancing their respective businesses with great passion and ambitions for profitable growth. They have built strong teams and created good foundations for their successors and Sonova. I am very grateful for their dedication and significant contributions to our company over many years.”
–Arnd Kaldowski, CEO of Sonova
Beck and Lux have been promoted from within, leveraging Sonova’s talent pipeline. Both have delivered strong results, possess commercial expertise, understand consumer needs, and have demonstrated operational excellence and leadership capabilities in various senior positions across different regions and businesses at Sonova. Their appointments will take effect in June.
Simpson, an experienced business executive with a successful track record in managing P&Ls, marketing, sales, and R&D functions, brings expertise in highly regulated medical devices. He has held senior leadership positions at companies including Johnson & Johnson, Danaher, and LivaNova. Simpson will assume the GVP Cochlear Implants role on July 1, 2024, after an immersion period, based in Valencia, California, at the Advanced Bionics headquarters.
“We are excited that these three experienced leaders join our Management Board,” said Kaldowski. “They will enable us to continue the successful strategy execution in the three businesses, aiming to drive profitable growth through innovation and expansion of our customer access.”
Source: Sonova
